Strategia di gestione delle sindromi coronariche acute

Thygesen, 2012, Third universal definition of myocardial infarction, Eur Heart J, 33, 2551, 10.1093/eurheartj/ehs184 Roffi, 2016, Eur Heart J, 37, 267, 10.1093/eurheartj/ehv320 Piepoli, 2016, Eur Heart J, 37, 2315, 10.1093/eurheartj/ehw106 Sugiyama, 2015, Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001–2011, J Am Heart Assoc, 4, e001445, 10.1161/JAHA.114.001445 McManus, 2011, Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI, Am J Med, 124, 40, 10.1016/j.amjmed.2010.07.023 Widimsky, 2010, European Association for Percutaneous Cardiovascular Interventions Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries, Eur Heart J, 31, 943, 10.1093/eurheartj/ehp492 Mozaffarian, 2015, Heart disease and stroke statistics—2015 update: a report from the American Heart Association, Circulation, 131, e29 Gehrie, 2009, Am Heart J, 158, 688, 10.1016/j.ahj.2009.08.004 Pasupathy, 2015, Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries, Circulation, 131, 861, 10.1161/CIRCULATIONAHA.114.011201 Niccoli, 2015, Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management, Eur Heart J, 36, 475, 10.1093/eurheartj/ehu469 Agewall, 2017, on behalf of the WG on Cardiovascular Pharmacotherapy ESC working group position paper on myocardial infarction with non-obstructive coronary arteries, Eur Heart J, 38, 143 Khera, 2015, Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States, J Am Coll Cardiol, 66, 1961, 10.1016/j.jacc.2015.08.865 Kristensen, 2014, Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries, Eur Heart J, 35, 1957, 10.1093/eurheartj/eht529 Pedersen, 2014, Short- and long-term cause of death in patients treated with primary PCI for STEMI, J Am Coll Cardiol, 64, 2101, 10.1016/j.jacc.2014.08.037 Fokkema, 2013, Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry), J Am Coll Cardiol, 61, 1222, 10.1016/j.jacc.2013.01.007 Terkelsen, 2010, System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention, JAMA, 304, 763, 10.1001/jama.2010.1139 2017, Eur Heart, J, 38, 1, 10.1093/eurheartj/ehw674 Wiel E, Assez N, Goldstein P. Stratégie de prise en charge des syndromes coronariens aigus. EMC - Médecine d’urgence 2012; 7(4):1–15.[Article 25-020-B-20]. Libby, 2013, Mechanisms of acute coronary syndromes and their implications for therapy, N Engl J Med, 368, 2004, 10.1056/NEJMra1216063 de Torbal, 2006, Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam study, Eur Heart J, 27, 729, 10.1093/eurheartj/ehi707 Campeau, 1976, Letter: grading of angina pectoris, Circulation, 54, 522, 10.1161/circ.54.3.947585 Devon, 2014, Sensitivity, specificity, and sex differences in symptoms reported on the 13-item acute coronary syndrome checklist, J Am Heart Assoc, 3, e000586, 10.1161/JAHA.113.000586 Regitz-Zagrosek, 2016, Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes, Eur Heart J, 37, 24, 10.1093/eurheartj/ehv598 Szymanski C, Manzo-Siberman. Causes, analyse de la sous-évaluation des syndromes coronaires aigus et des disparités en France chez les femmes : registre CASSANDRE. Actualités sur les grands essais cliniques (II). XXIIe Journées européennes de la société française de cardiologie. Paris, 2012. Puymirat, 2012, Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction, JAMA, 308, 998, 10.1001/2012.jama.11348 Rubini Gimenez, 2014, Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction, JAMA Intern Med, 174, 241, 10.1001/jamainternmed.2013.12199 2016, Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) authors/task force, members, Eur Heart, J, 37, 267 Bassand, 2007, Task force for diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the ESC guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes, Eur Heart J, 28, 1598, 10.1093/eurheartj/ehm161 Tubaro, 2011, Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology, Acute Card Care, 13, 56, 10.3109/17482941.2011.581292 Quinn, 2014, Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project, Heart, 100, 944, 10.1136/heartjnl-2013-304599 From, 2010, Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation, Am J Cardiol, 106, 1081, 10.1016/j.amjcard.2010.06.016 Rokos, 2012, Correlation between index electrocardiographic patterns and pre-intervention angiographic findings: insights from the HORIZONS-AMI trial, Catheter Cardiovasc Interv, 79, 1092, 10.1002/ccd.23262 Stribling, 2011, Left circumflex occlusion in acute myocardial infarction (from the National Cardiovascular Data Registry), Am J Cardiol, 108, 959, 10.1016/j.amjcard.2011.05.027 Wang, 2009, Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-STelevation acute coronary syndromes undergoing diagnostic angiography, Am Heart J, 157, 716, 10.1016/j.ahj.2009.01.004 Lopes, 2011, Diagnosing acute myocardial infarction in patients with left bundle branch block, Am J Cardiol, 108, 782, 10.1016/j.amjcard.2011.05.006 Widimsky, 2012, Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?, Eur Heart J, 33, 86, 10.1093/eurheartj/ehr291 Sgarbossa, 1998, Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era GUSTO-I Investigators. Global Utilization of stretptokinase and t-PA for occluded coronary arteries, J Am Coll Cardiol, 31, 105, 10.1016/S0735-1097(97)00446-4 Neeland, 2012, Evolving considerations in the management of patients with left bundle branch block and suspected myocardial infarction, J Am Coll Cardiol, 60, 96, 10.1016/j.jacc.2012.02.054 Liakopoulos, 2013, Left bundle branch block and suspected myocardial infarction: does chronicity of the branch block matter?, Eur Heart J Acute Cardiovasc Care, 2, 182, 10.1177/2048872613483589 Savonitto, 1999, Prognostic value of the admission electrocardiogram in acute coronary syndromes, JAMA, 281, 707, 10.1001/jama.281.8.707 Henrikson, 2003, Chest pain relief by nitroglycerin does not predict active coronary artery disease, Ann Intern Med, 139, 979, 10.7326/0003-4819-139-12-200312160-00007 Larsen, 2012, Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest: a systematic review and meta-analysis, Resuscitation, 83, 1427, 10.1016/j.resuscitation.2012.08.337 Mueller, 2014, Biomarkers and acute coronary syndromes: an update, Eur Heart J, 35, 552, 10.1093/eurheartj/eht530 Thygesen, 2012, How to use high-sensitivity cardiac troponins in acute cardiac care, Eur Heart J, 33, 2252, 10.1093/eurheartj/ehs154 Cullen, 2013, Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome, J Am Coll Cardiol, 62, 1242, 10.1016/j.jacc.2013.02.078 Rubini Gimenez, 2013, Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin, Int J Cardiol, 168, 3896, 10.1016/j.ijcard.2013.06.049 Reichlin, 2012, One-hour rule out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T, Arch Intern Med, 172, 1211, 10.1001/archinternmed.2012.3698 Zhelev, 2015, Diagnostic accuracy of single baseline measurement of Elecsys troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis, BMJ, 350, h15, 10.1136/bmj.h15 Twerenbold, 2015, Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction, Circulation, 131, 2041, 10.1161/CIRCULATIONAHA.114.014245 Than, 2012, 2-hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial, J Am Coll Cardiol, 59, 2091, 10.1016/j.jacc.2012.02.035 Steengard, 2017, The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin, Biomarkers, 22, 351, 10.1080/1354750X.2016.1265008 Fox, 2014, Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score, BMJ Open, 4, e004425, 10.1136/bmjopen-2013-004425 Subherwal, 2009, Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) bleeding score, Circulation, 119, 1873, 10.1161/CIRCULATIONAHA.108.828541 Antman, 2000, The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making, JAMA, 284, 835, 10.1001/jama.284.7.835 Stub, 2015, Air versus oxygen in ST-segment-elevation myocardial infarction, Circulation, 131, 2143, 10.1161/CIRCULATIONAHA.114.014494 Alexander, 2005, Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes, JAMA, 294, 3108, 10.1001/jama.294.24.3108 Bueno, 2011, Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies, Eur Heart J, 32, 51, 10.1093/eurheartj/ehq375 Zeymer, 2017, Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i.v. and 300 mg p.o. in ACS (ACUTE), Thromb Haemost, 117, 625, 10.1160/TH16-08-0650 Montalescot, 2014, Prehospital ticagrelor in ST-segment elevation myocardial infarction, N Engl J Med, 371, 1016, 10.1056/NEJMoa1407024 Montalescot, 2013, Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes, N Engl J Med, 369, 999, 10.1056/NEJMoa1308075 Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482 Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327 Roe, 2012, Prasugrel versus clopidogrel for acute coronary syndromes without revascularization, N Engl J Med, 367, 1297, 10.1056/NEJMoa1205512 James, 2010, Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial, Eur Heart J, 31, 3006, 10.1093/eurheartj/ehq325 Bhatt, 2013, Effect of platelet inhibition with cangrelor during PCI on ischemic events, N Engl J Med, 368, 1303, 10.1056/NEJMoa1300815 Steg, 2013, Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data, Lancet, 382, 1981, 10.1016/S0140-6736(13)61615-3 Ellis, 2008, Facilitated PCI in patients with ST-elevation myocardial infarction, N Engl J Med, 358, 2205, 10.1056/NEJMoa0706816 Mega, 2010, Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis, Lancet, 376, 1312, 10.1016/S0140-6736(10)61273-1 Trenk, 2008, Cytochrome P450 2C19 681GA polymorphism and high on clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents, J Am Coll Cardiol, 51, 1925, 10.1016/j.jacc.2007.12.056 Montalescot, 2011, Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for STelevation myocardial infarction: the international randomised open-label ATOLL trial, Lancet, 378, 693, 10.1016/S0140-6736(11)60876-3 Collet, 2013, A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial), Am J Cardiol, 112, 1367, 10.1016/j.amjcard.2013.07.003 Silvain, 2012, Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis, BMJ, 344, e553, 10.1136/bmj.e553 Yusuf, 2006, Effects of fondaparinux on mortality and reinfarction in patients with acute ST segment elevation myocardial infarction: the OASIS-6 randomized trial, JAMA, 295, 1519, 10.1001/jama.295.13.joc60038 Capodanno, 2016, Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: an updated meta-analysis of 10,350 patients from five randomized clinical trials, Eur Heart J acute Cardiovasc Care, 5, 253, 10.1177/2048872615572599 Han, 2015, Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial, JAMA, 313, 1336, 10.1001/jama.2015.2323 Zeymer, 2014, Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial, Eur Heart J, 35, 2460, 10.1093/eurheartj/ehu214 Leonardi, 2016, Bivalirudin or unfractioned heparin in patients with acute coronary syndromes managed invasively with or without ST elevation (MATRIX): randomized controlled trial, BMJ, 354, i4935, 10.1136/bmj.i4935 Wallentin, 2003, Circulation, 108, 135, 10.1161/01.CIR.0000081659.72985.A8 Cassese, 2016, Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomized controlled trials, Lancet, 387, 537, 10.1016/S0140-6736(15)00979-4 Ndrepepa, 2008, Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point, J Am Coll Cardiol, 51, 690, 10.1016/j.jacc.2007.10.040 Kim, 2012, A new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation), J Am Coll Cardiol, 60, 1340, 10.1016/j.jacc.2012.06.043 Feres, 2013, Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial, JAMA, 310, 2510 Palmerini, 2015, Mortality in patients treated with extended duration dual antiplatelet therapy after drugeluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials, Lancet, 385, 2371, 10.1016/S0140-6736(15)60263-X Costa, 2017, Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials, Lancet, 389, 1025, 10.1016/S0140-6736(17)30397-5 Franchi, 2016, Pharmacodynamic effects of switching from prasugrel to ticagrelor: results of the prospective, randomized SWAP-3 study, JACC Cardiovasc Interv, 9, 1089, 10.1016/j.jcin.2016.02.039 Gershlick, 2005, Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction, N Engl J Med, 353, 2758, 10.1056/NEJMoa050849 Hochman, 2001, One-year survival following early revascularization for cardiogenic shock, JAMA, 285, 190, 10.1001/jama.285.2.190 2012, Task Force on the management of ST-segment elevationsacute myocardial infarction of the European Society of Cardiology (ESC), ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment, elevation, Eur Heart J, 33, 2569, 10.1093/eurheartj/ehs215 Armstrong, 2013, Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction, N Engl J Med, 368, 1379, 10.1056/NEJMoa1301092 Bonnefoy, 2009, Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up, Eur Heart J, 30, 1598, 10.1093/eurheartj/ehp156 Toleva, 2015, Treatment choices in elderly patients with ST: elevation myocardial infarction-insights from the Vital Heart Response registry, Open Heart, 2, e000235, 10.1136/openhrt-2014-000235 Malkin, 2012, The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry, BMJ Open, 2, e000540, 10.1136/bmjopen-2011-000540 White, 2000, Thrombolytic therapy in the elderly, Lancet, 356, 2028, 10.1016/S0140-6736(00)03397-3 Madan, 2015, JACC Cardiovasc Interv, 8, 166, 10.1016/j.jcin.2014.09.005 Fernandez-Aviles, 2004, Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial, Lancet, 364, 1045, 10.1016/S0140-6736(04)17059-1 Le May, 2005, Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study), J Am Coll Cardiol, 46, 417, 10.1016/j.jacc.2005.04.042 Morrison, 2000, Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis, JAMA, 283, 2686, 10.1001/jama.283.20.2686 Gierlotka, 2011, Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]), Am J Cardiol, 107, 501, 10.1016/j.amjcard.2010.10.008 Wang, 2011, Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention, JAMA, 305, 2540, 10.1001/jama.2011.862 Bottiger, 2008, Thrombolysis during resuscitation for outof- hospital cardiac arrest, N Engl J Med, 359, 2651, 10.1056/NEJMoa070570 Monsieurs, 2015, European resuscitation council guidelines for resuscitation 2015: section 1 executive summary, Resuscitation, 95, 1, 10.1016/j.resuscitation.2015.07.038 Noc, 2014, Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)/Stent for LIfe (SFL) groups, EuroIntervention, 10, 31, 10.4244/EIJV10I1A7 Thiele, 2012, Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig immediate vs early and late percutaneous coronary intervention trial in NSTEMI (LIPSIA-NSTEMI trial), Eur Heart J, 33, 2035, 10.1093/eurheartj/ehr418 Fox, 2010, Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data, J Am Coll Cardiol, 55, 2435, 10.1016/j.jacc.2010.03.007 Navarese, 2013, Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis, Ann Intern Med, 158, 261, 10.7326/0003-4819-158-4-201302190-00006 Amsterdam, 2010, Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association, Circulation, 122, 1756, 10.1161/CIR.0b013e3181ec61df Gorenek, 2014, Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA ACCA, and EAPCI task force, Europace, 16, 1655, 10.1093/europace/euu208 Cheng, 2009, Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials, Eur Heart J, 30, 2102, 10.1093/eurheartj/ehp292 Hausenloy, 2017, Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations, Eur Heart J, 38, 935